The Absence of Platelet-Derived Growth Factor-B in Circulating Cells Promotes Immune and Inflammatory Responses in Atherosclerosis-Prone ApoE−/− Mice
- 30 September 2005
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 167 (3) , 901-912
- https://doi.org/10.1016/s0002-9440(10)62061-5
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- CD4+CD25+ regulatory T cells: I. Phenotype and physiologyAPMIS, 2004
- Immunomodulation and vaccination for atherosclerosisExpert Opinion on Biological Therapy, 2004
- Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous AntigenScandinavian Journal of Immunology, 2004
- Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell DevelopmentPLoS Biology, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF β-receptor null miceBlood, 2001
- PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokinesBiochemical and Biophysical Research Communications, 1992
- Platelet-derived growth factor is a potent biologic response modifier of T cells.The Journal of Experimental Medicine, 1991
- Inhibition of Human Natural Killer Cell Activity by Platelet‐Derived Growth Factor (PDGF)Scandinavian Journal of Immunology, 1991
- Localization of PDGF-B Protein in Macrophages in All Phases of AtherogenesisScience, 1990